Events Calendar

Mon
Tue
Wed
Thu
Fri
Sat
Sun
M
T
W
T
F
S
S
27
12:00 AM - Arab Health 2020
29
1
7
10
12
14
16
20
23
25
27
28
29
1
Arab Health 2020
2020-01-27 - 2020-01-30    
All Day
ABOUT ARAB HEALTH 2020 Arab Health is an industry-defining platform where the healthcare industry meets to do business with new customers and develop relationships with [...]
12th International Conference on Acute Cardiac Care
2020-01-28 - 2020-01-29    
All Day
ABOUT 12TH INTERNATIONAL CONFERENCE ON ACUTE CARDIAC CARE Acute Cardiac Care has been undergoing a substantial transformation in recent years as the population ages and [...]
30 Jan
2020-01-30 - 2020-01-31    
All Day
The ICMHS conference is an international forum for the presentation of technological advances and research results in the fields of Medical and Health Sciences. The [...]
Annual Lower and Upper Canada Anesthesia Symposium 2020 (LUCAS)
2020-01-31 - 2020-02-02    
All Day
ABOUT ANNUAL LOWER & UPPER CANADA ANESTHESIA SYMPOSIUM 2020 (LUCAS) On behalf of the Departments of Anesthesia of McGill University, Queen’s University, and the University [...]
RF - 577th International Conference On Medical & Health Science - ICMHS 2020
2020-02-02 - 2020-02-03    
All Day
577th International Conference on Medical & Health Science - ICMHS 2020. It will be held during 2nd-3rd February, 2020 at Berlin , Germany. ICMHS 2020 [...]
ISER- 747th International Conference On Science, Health And Medicine ICSHM
2020-02-02 - 2020-02-03    
All Day
ISER- 747th International Conference on Science, Health and Medicine ICSHM is a prestigious event organized with a motivation to provide an excellent international platform for [...]
International Conference On Medical And Health SciencesICMHS-2020
2020-02-03 - 2020-02-04    
All Day
The ICMHS conference is an international forum for the presentation of technological advances and research results in the fields of Medical and Health Sciences. The [...]
Medlab Middle East 2020
2020-02-03 - 2020-02-06    
All Day
ABOUT MEDLAB MIDDLE EAST 2020 Medlab Middle East is the only medical laboratory industry event that offers manufacturers the opportunity to meet a diverse audience [...]
Cloud Architecture Implementation Healthcare 2020
2020-02-04 - 2020-02-06    
All Day
This summit brings together leaders from healthcare organizations to scale up their cloud infrastructure, implement cloud technology and share use cases about the success and [...]
4th Microbiome Movement - Drug Development Summit Europe 2020 - London, UK
2020-02-04 - 2020-02-06    
All Day
A unique forum focusing on pursuing disease causation to foster the creation of targeted Microbiome-based therapeutics, biomarkers and diagnostics. Time: 8:30 am - 5:50 pm [...]
Structural Heart Intervention And Imaging Feb 2020 CME Conference-San Diego
2020-02-05 - 2020-02-07    
All Day
The Scripps Structural Heart Intervention and Imaging conference features live case demonstrations, lectures from renowned faculty, hands-on workshops, and extensive satellite symposia. Time: 7:00 am [...]
Structural Heart Intervention And Imaging Feb 2020 CME Conference-San Diego
2020-02-05 - 2020-02-07    
All Day
The Scripps Structural Heart Intervention and Imaging conference features live case demonstrations, lectures from renowned faculty, hands-on workshops, and extensive satellite symposia. Time: 7:00 am [...]
18th Annual South Beach Symposium
2020-02-06 - 2020-02-09    
All Day
ABOUT 18TH ANNUAL SOUTH BEACH SYMPOSIUM The 18th Annual South Beach Symposium will take place in Miami Beach, Florida from February 6-9, 2020 at the [...]
Primary Care CME In Clearwater Beach, Florida February 2020
2020-02-08 - 2020-02-10    
All Day
Topics include latest hypertension guidelines, cancer screening, cholesterol management, immunizations, COPD, skin and soft tissue infections, etc. Time: 08:00 - 11:00
Primary Care CME In Clearwater Beach, Florida February 2020
2020-02-08 - 2020-02-10    
All Day
Topics include latest hypertension guidelines, cancer screening, cholesterol management, immunizations, COPD, skin and soft tissue infections, etc. Time: 08:00 - 11:00  
World Congress On Medical Imaging And Clinical Research WCMICR-2020
2020-02-09 - 2020-02-10    
All Day
The WCMICR conference is an international forum for the presentation of technological advances and research results in the fields of Medical Imaging and Clinical Research. [...]
Medical Design & Manufacturing (MD&M) West
2020-02-11 - 2020-02-13    
All Day
ABOUT MEDICAL DESIGN & MANUFACTURING (MD&M) WEST Medical Design & Manufacturing (MD&M) West is where serious professionals find the technologies, education, and connections to stay [...]
Third International Conference On Zika Virus And Aedes Related Infections
2020-02-13    
All Day
This Conference will bring together multidisciplinary experts aiming to tackle the challenges that Aedes related infections present including zika, dengue, yellow fever, and chikungunya. Time: [...]
The IRES - 791st International Conferences On Medical And Health Science ICMHS
2020-02-15 - 2020-02-16    
All Day
The IRES - 791st International Conferences on Medical and Health Science ICMHS aimed at presenting current research being carried out in that area and scheduled [...]
4th International Conference on Chronic Diseases
2020-02-17 - 2020-02-18    
All Day
ABOUT 4TH INTERNATIONAL CONFERENCE ON CHRONIC DISEASES It takes immense pleasure to invite you to attend the 4th International Conference on Chronic Diseases (Chronic Diseases [...]
European Gynecology and Obstetrics Congress
2020-02-17 - 2020-02-18    
All Day
ABOUT EUROPEAN GYNECOLOGY AND OBSTETRICS CONGRESS Gynecology 2020 destine to endeavor leading-edge memoranda of eminent keynote speakers, universal personalities, special sessions and poster presentations attracting [...]
18 Feb
2020-02-18 - 2020-02-20    
All Day
Technology Networks is a global online scientific publication that covers the latest research, industry news, and technologies. Our 12 online communities provide focused coverage of [...]
6th International Conference On Food And Beverages
2020-02-19 - 2020-02-20    
All Day
Meetings International Meetings Int. invites you to attend the ‘6th International Conference on Food and Beverages 2020” which is to be held on February 19-20, [...]
10th Global Summit on Neuroscience and Neuroimmunology
2020-02-19 - 2020-02-20    
All Day
ABOUT 10TH GLOBAL SUMMIT ON NEUROSCIENCE AND NEUROIMMUNOLOGY 10th Global Summit on Neuroscience and Neuroimmunology (Neuroimmunology 2020) is aimed at improving health across the globe, [...]
Mayo Clinic Nephrology And Transplantation For The Clinician 2020
2020-02-21 - 2020-02-22    
All Day
Nephrology and Transplantation for the Clinician: 18th Annual Update From Mayo Clinic is a two-day course designed to u-p-d-a-t-e participants on nephrology topics relevant to [...]
28th International Conference on Cancer Research and Pharmacology
2020-02-21 - 2020-02-22    
All Day
ABOUT 28TH INTERNATIONAL CONFERENCE ON CANCER RESEARCH AND PHARMACOLOGY PULSUS Conferences is glad to invite all the participants across the globe to attend 28th International [...]
Rocky Mountain Winter Conference On Emergency Medicine 2020
2020-02-22 - 2020-02-26    
All Day
Each day the conference starts with a hot breakfast followed by engaging, cutting edge didactics led by experts from the countrys top academic programs. Please [...]
CRT20 Conference
2020-02-22 - 2020-02-25    
All Day
ABOUT CRT20 CONFERENCE CRT, one of the world’s leading interventional cardiology conferences, is attended by more than 3,000 interventional and endovascular specialists. At the 2019 [...]
3rd International conference on  Diabetes, Hypertension and Metabolic Syndrome
2020-02-24 - 2020-02-25    
All Day
About Diabetes Meet 2020 Conference Series takes the immense Pleasure to invite participants from all over the world to attend the 3rdInternational conference on Diabetes, Hypertension and [...]
3rd International Conference on Cardiology and Heart Diseases
2020-02-24 - 2020-02-25    
All Day
ABOUT 3RD INTERNATIONAL CONFERENCE ON CARDIOLOGY AND HEART DISEASES The standard goal of Cardiology 2020 is to move the cardiology results and improvements and to [...]
Medical Device Development Expo OSAKA
2020-02-26 - 2020-02-28    
All Day
ABOUT MEDICAL DEVICE DEVELOPMENT EXPO OSAKA What is Medical Device Development Expo OSAKA (MEDIX OSAKA)? Gathers All Kinds of Technologies for Medical Device Development! This [...]
Events on 2020-01-27
Arab Health 2020
27 Jan 20
Dubai
Events on 2020-01-28
Events on 2020-01-30
Events on 2020-01-31
Events on 2020-02-03
Events on 2020-02-06
18th Annual South Beach Symposium
6 Feb 20
Miami Beach
Events on 2020-02-09
Events on 2020-02-11
Events on 2020-02-17
Events on 2020-02-18
18 Feb
Events on 2020-02-22
CRT20 Conference
22 Feb 20
National Harbor
Events on 2020-02-26
Latest News

AMN Healthcare Announces First Quarter 2015 Results

amn healthcare

AMN Healthcare Services, Inc. (NYSE: AHS), healthcare’s innovator in workforce solutions and staffing services, today announced first quarter 2015 financial results exceeding the Company’s guidance for revenue and adjusted EBITDA. First quarter financial highlights are as follows:

Dollars in millions, except per share amounts.

Q1 2015 % Change

Q1 2014

Revenue $327.5 36%
Gross profit $101.4 37%
Net income $12.2 60%
Diluted EPS $0.25 56%
Adjusted Diluted EPS* $0.30 67%
Adjusted EBITDA* $33.3 58%

*  See “Non-GAAP Measures” below for a discussion of our use of non-GAAP items and the table entitled “Supplemental Financial and Operating Data” for a reconciliation of non-GAAP items.

  • Consolidated revenue increased 36% year-over-year, driven by organic revenue growth of 22% with the remainder from acquisitions.
  • Gross margin of 31.0% represented an improvement of 30 basis points from the prior year and 70 basis points from the prior quarter.
  • Adjusted EBITDA margin of 10.2% reflected a 140 basis point improvement from the prior year.
  • Adjusted EPS of $0.30 (which excludes amortization of intangible assets and acquisition and integration-related expenses) grew 67% from the prior year.
  • AMN’s leading workforce solutions portfolio continues to grow and create opportunities to help healthcare providers through multiple service lines.

“Amid positive trends in the healthcare industry, we continued to experience strong demand and outstanding execution across all business segments, resulting in better than anticipated revenue and profitability growth during the first quarter,” said Susan R. Salka, President and Chief Executive Officer of AMN Healthcare. “The pipeline of opportunities for our strategic workforce solutions offerings remains strong, and our recently added Avantas, Onward Healthcare, Locum Leaders and Medefis companies are performing and integrating very well into AMN’s service offerings. Our portfolio of differentiated workforce solutions and stronger recruitment and supply capabilities, combined with the favorable market conditions and the exceptional performance by our team, give us a continued optimistic outlook for 2015.”

First Quarter 2015 Results

For the first quarter of 2015, consolidated revenue was $328 million, an increase of 36% from the same quarter last year and 17% sequentially. First quarter revenue for the Nurse and Allied Healthcare Staffing segment was $229 million, up 40% (24% excluding acquisitions) from the same quarter last year and 20% sequentially. Locum Tenens Staffing segment revenue in the first quarter was$87 million, an increase of 30% (19% excluding acquisitions) from the same quarter last year and up 14% sequentially. First quarter Physician Permanent Placement Services segment revenue was $12 million, an increase of 11% from the same quarter last year and lower by 1% sequentially.

First quarter gross margin of 31.0% was higher by 30 basis points than the same quarter last year and higher by 70 basis points sequentially. The year-over-year and sequential gross margin improvements were driven both by organic and acquisition revenue growth of higher-margin workforce solutions businesses.

SG&A expenses for the first quarter were $72 million, representing 21.8% of revenue, compared to 22.7% in the same quarter last year and 22.1% in the prior quarter. The year-over-year and sequential improvements in SG&A expenses as a percentage of revenue were due primarily to operating leverage associated with the revenue growth. SG&A expenses in the quarter included $1 million of acquisition and integration-related expenses.

First quarter net income was $12 million and net income per diluted share was $0.25. Excluding the impact of amortization of intangible assets of $3 million and acquisition and integration-related expenses of $1 million, adjusted net income per diluted share was $0.30. First quarter adjusted EBITDA was $33 million, a year-over-year increase of 58% and sequential increase of 32%. First quarter adjusted EBITDA margin of 10.2% represented a 140 basis point increase over prior year and 120 basis point increase from the prior quarter.

At March 31, 2015, cash and cash equivalents totaled $12 million. First quarter cash flow from operations was $9 million and capital expenditures were $6 million. The Company ended the first quarter with total debt outstanding of $238 million, with a leverage ratio of 2.2 to 1.

Business Trends and Outlook

The Company expects consolidated second quarter 2015 revenue of $335 to $340 million. Gross margin is expected to be 30.5% to 31.0%. SG&A expenses as a percentage of revenue are expected to be 22.0% to 22.5%, slightly higher than first quarter due to increases in employee and other expenses to deliver consistent quality service to our clients. Integration-related expenses are expected to be approximately $1 million. Adjusted EBITDA margin is expected to be approximately 9.5%.

About AMN Healthcare

AMN Healthcare is the leader and innovator in healthcare workforce solutions and staffing services to healthcare facilities across the nation. AMN Healthcare’s workforce solutions – including managed services programs, vendor management systems, recruitment process outsourcing and consulting services – enable providers to successfully reduce complexity, increase efficiency and improve patient outcomes within the rapidly evolving healthcare environment. The Company provides unparalleled access to the most comprehensive network of quality healthcare professionals through its innovative recruitment strategies and breadth of career opportunities. Clients include acute-care hospitals, community health centers and clinics, physician practice groups, retail and urgent care centers, home health facilities, and many other healthcare settings. AMN Healthcare disseminates news and information about the Company through its website, which can be found at www.amnhealthcare.com.

Conference Call on May 7, 2015

AMN Healthcare Services, Inc.’s first quarter 2015 conference call will be held on Thursday, May 7, 2015, at 5:00 p.m. Eastern Time. A live webcast of the call can be accessed through AMN Healthcare’s website athttp://amnhealthcare.investorroom.com/presentations. Please log in at least 10 minutes prior to the conference call in order to download the applicable audio software. Interested parties may participate live via telephone by dialing (800) 230-1059 in the U.S. or (612) 234-9959 internationally. Following the conclusion of the call, a replay of the webcast will be available at the Company’s website. A telephonic replay of the call will be available at 7:30 p.m. Eastern Time on May 7, 2015, and can be accessed until 11:59 p.m. Eastern Time on May 21, 2015, by calling (800) 475-6701 in the U.S. or (320) 365-3844 internationally, with access code 357522.

Non-GAAP Measures

This earnings release contains certain non-GAAP financial information, which the Company provides as additional information, and not as an alternative, to the Company’s condensed consolidated financial statements presented in accordance with GAAP. These non-GAAP financial measures include (1) adjusted EBITDA, (2) adjusted EBITDA margin, and (3) adjusted diluted  EPS.  The Company provides such non-GAAP financial measures because management believes that they are useful both to management and investors as a supplement, and not as a substitute, when evaluating the Company’s operating performance. Additionally, management believes that adjusted EBITDA, adjusted EBITDA margin and adjusted diluted EPS serve as industry-wide financial measures, and it uses adjusted EBITDA for making financial decisions and allocating resources. The non-GAAP measures in this release are not in accordance with, or an alternative to, GAAP, and may be different from non-GAAP measures, or may be calculated differently than other similarly title-captioned non-GAAP measures, reported by other companies. They should not be used in isolation to evaluate the Company’s performance.  A reconciliation of non-GAAP measures identified in this release, along with further detail about the use and limitations of certain of these non-GAAP measures, may be found below in the table entitled Supplemental Financial and Operating Data under the caption entitled “Reconciliation of Non-GAAP Items” or on the Company’s website athttp://amnhealthcare.investorroom.com/financialreports. Additionally, from time to time, additional information regarding non-GAAP financial measures, including pro forma measures, may be made available on the Company’s website.

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements include expectations regarding the 2015 outlook and second quarter revenue, gross margin, SG&A expenses, integration-related expenses and adjusted EBITDA margin. The Company based these forward-looking statements on its current expectations, estimates and projections about future events and the industry in which it operates using information currently available to it. Actual results could differ materially from those discussed in, or implied by, these forward-looking statements. Forward-looking statements are identified by words such as “believe,” “anticipate,” “expect,” “intend,” “plan,” “will,” “may,” “estimates,” variations of such words and other similar expressions. In addition, any statements that refer to expectations, projections or other characterizations of future events or circumstances are forward-looking statements. Factors that could cause actual results to differ from those implied by the forward-looking statements contained in this press release are set forth in the Company’s Annual Report on Form 10-K for the year ended December 31, 2014 and its other periodic reports as well as the Company’s current and other reports filed from time to time with the Securities and Exchange Commission. Be advised that developments subsequent to this press release are likely to cause these statements to become outdated with the passage of time.

Contact:
Amy C. Chang
Vice President, Investor Relations
866.861.3229

AMN Healthcare Services, Inc.
Condensed Consolidated Statements of Comprehensive Income
(in thousands, except per share amounts)
(unaudited)
Three Months Ended
March 31, December 31,
2015 2014 2014
Revenue $     327,510 $     240,881 $     279,649
Cost of revenue 226,078 166,925 194,953
Gross profit 101,432 73,956 84,696
31.0% 30.7% 30.3%
Operating expenses:
Selling, general and administrative 71,552 54,667 61,668
21.8% 22.7% 22.1%
Depreciation and amortization 5,095 3,820 4,077
Total operating expenses 76,647 58,487 65,745
Income from operations 24,785 15,469 18,951
Interest expense, net, and other 1,807 1,846 1,329
Income before income taxes 22,978 13,623 17,622
Income tax expense 10,769 5,993 7,727
Net income $       12,209 $       7.630 $         9,895
Net income per common share:
Basic $           0.26 $           0.16 $           0.21
Diluted $           0.25 $           0.16 $           0.20
Weighted average common shares outstanding:
Basic 47,146 46,354 46,634
Diluted 48,364 47,917 48,462
Other comprehensive income (loss) 68 (9) 113
Comprehensive income $       12,277 $         7,621 $       10,008
AMN Healthcare Services, Inc.
Supplemental Financial and Operating Data
(dollars in thousands, except per share and operating data)
(unaudited)
Three Months Ended
March 31, December 31,
2015 2014 2014
Revenue
Nurse and allied healthcare staffing $ 229,046 $ 163,450 $ 191,570
Locum tenens staffing 86,692 66,871 76,170
Physician permanent placement services 11,772 10,560 11,909
$ 327,510 $ 240,881 $ 279,649
Reconciliation of Non-GAAP Items:
Segment operating income (1)
Nurse and allied healthcare staffing $ 31,901 $ 19,972 $ 23,963
Locum tenens staffing 9,110 6,873 8,155
Physician permanent placement services 3,271 2,131 2,744
44,282 28,976 34,862
Unallocated corporate overhead 10,960 7,868 9,601
Adjusted EBITDA (2) 33,322 21,108 25,261
Adjusted EBITDA margin (3) 10.2% 8.8% 9.0%
Depreciation and amortization 5,095 3,820 4,077
Share-based compensation 2,377 1,819 1,796
Acquisition and integration costs 1,065 0 437
Interest expense, net and other 1,807 1,846 1,329
Income before income taxes 22,978 13,623 17,622
Income tax expense 10,769 5,993 7,727
Net income $ 12,209 $ 7,630 $ 9,895
GAAP based diluted net income per share (EPS) $0.25 $0.16 $0.20
Adjustments (net of tax):
Amortization of intangible assets $0.04 $0.02 $0.02
Acquisition and integration costs $0.01 $0.00 $0.01
Adjusted diluted EPS (4) $0.30 $0.18 $0.23
Three Months Ended
March 31, December 31,
2015 2014 2014
Gross Margin
Nurse and allied healthcare staffing 29.8% 29.0% 28.6%
Locum tenens staffing 29.4% 29.9% 28.8%
Physician permanent placement services 65.7% 63.0% 66.1%
Operating Data:
Nurse and allied healthcare staffing
Average clinicians on assignment (5) 7,223 5,633 6,030
Locum tenens staffing
Days filled (6) 54,260 44,749 48,391
As of March 31 As of December 31,
2015 2014 2014
Leverage ratio (7) 2.2 2.0 1.9
AMN Healthcare Services, Inc.
Condensed Consolidated Balance Sheets
(dollars in thousands)
(unaudited)
March 31, December 31,
2015 2014
Assets
Current assets:
Cash and cash equivalents $ 11,633 $ 13,073
Accounts receivable, net 221,001 186,274
Accounts receivable, subcontractor 34,191 28,443
Deferred income taxes, net 26,466 27,330
Prepaid and other current assets 29,065 27,550
Total current assets 322,356 282,670
Restricted cash, cash equivalents and investments 19,772 19,567
Fixed assets, net 36,674 32,880
Other assets 44,117 39,895
Goodwill 197,254 154,387
Intangible assets, net 179,877 152,517
Total assets $ 800,050 $ 681,916
Liabilities and stockholders’ equity
Current liabilities:
Accounts payable and accrued expenses 92,081 78,993
Accrued compensation and benefits 72,237 67,995
Current portion of revolving credit facility 30,000 18,000
Current portion of notes payable 7,500 7,500
Deferred revenue 3,137 3,177
Other current liabilities 2,662 2,630
Total current liabilities 207,617 178,295
Revolving credit facility 65,500 0
Notes payable 135,000 136,875
Deferred income taxes, net 37,198 32,491
Other long-term liabilities 83,972 77,674
Total liabilities 529,287 425,335
Commitments and contingencies
Stockholders’ equity 270,763 256,581
Total liabilities and stockholders’ equity $ 800,050 $ 681,916
AMN Healthcare Services, Inc.
Condensed Consolidated Statements of Cash Flows
(dollars in thousands)
(unaudited)
Three Months Ended
March 31, December 31,
2015 2014 (8) 2014
Net cash provided by operating activities $ 8,687 $ 864 $ 5,039
Net cash used in investing activities (85,350) (4,709) (17,908)
Net cash provided by (used in) financing activities 75,155 (2,457) 16,166
Effect of exchange rates on cash 68 (9) 113
Net decrease in cash and cash equivalents (1,440) (6,311) 3,410
Cash and cash equivalents at beginning of period 13,073 15,580 9,663
Cash and cash equivalents at end of period $ 11,633 $ 9,269 $ 13,073
(1) Segment operating income represents net income plus interest expense (net of interest income), income taxes, depreciation and amortization, unallocated corporate overhead, acquisition and integration costs and share-based compensation expense.
(2) Adjusted EBITDA represents net income plus interest expense (net of interest income), income taxes, depreciation and amortization, acquisition and integration costs and share-based compensation expense. Management believes that adjusted EBITDA provides an effective measure of the Company’s results, as it excludes certain items that management believes are not indicative of the Company’s operating performance and considers measures used in credit facilities. Adjusted EBITDA is not intended to represent cash flows for the period, nor has it been presented as an alternative to income from operations or net income as an indicator of operating performance. Although management believes that some of the items excluded from adjusted EBITDA are not indicative of the Company’s operating performance, these items do impact the statement of comprehensive income, and management therefore utilizes adjusted EBITDA as an operating performance measure in conjunction with GAAP measures such as net income.
(3) Adjusted EBITDA margin represents adjusted EBITDA divided by revenue.
(4) Adjusted diluted EPS represents GAAP diluted EPS excluding the impact of 1) amortization of intangible assets; 2) acquisition and integration expenses; and 3) other non-recurring costs, such as debt extinguishment cost, in each case, net of tax. Adjusted diluted EPS for prior year and prior quarter have been restated to conform to the current year presentation. Management included this non-GAAP measure to provide investors and prospective investors with an alternative method for assessing the Company’s operating results in a manner that is focused on its operating performance and to provide a more consistent basis for comparison between quarters. However, investors should note that this non-GAAP measure involves judgment by management (in particular, judgment as to what items are excluded from adjusted diluted EPS). Although management believes the items excluded from adjusted diluted EPS are not indicative of the Company’s operating performance, these items do impact the statement of comprehensive income, and management therefore utilizes adjusted diluted EPS as an operating performance measure in conjunction with GAAP measures such as GAAP diluted EPS.
(5) Average clinicians on assignment represents the average number of nurse and allied healthcare professionals on assignment during the period presented.
(6) Days filled is calculated by dividing the locum tenens hours filled during the period by eight hours.
(7) Leverage ratio represents the ratio of the consolidated funded indebtedness (as calculated per the Company’s credit agreement) at the end of the period to the consolidated adjusted EBITDA (as calculated per the Company’s credit agreement) for the last twelve months.
(8) Certain reclassifications have been made to the condensed consolidated statements of cash flows for the three months ended March 31, 2014 to conform to the current year presentation.

 Source